Empfohlen
Weitere ähnliche Inhalte
Andere mochten auch
Ähnlich wie Vaccines India 2015 Conference Agenda & Abstracts
Ähnlich wie Vaccines India 2015 Conference Agenda & Abstracts (20)
Vaccines India 2015 Conference Agenda & Abstracts
- 1. http://vaccines.indoglobalsummit.com/ Vaccines India-2015 Organizing Committee Members Conference Secretariat 5716 Corsa Ave., Suite 110, West Lake, Los Angeles, CA 91362-7354, USA Ph: +1-650-268-9744, Fax: +1-650-618-1414, Toll free: +1-800-216-6499 Email: vaccines@omicsgroup.com; vaccinesindia@omicsgroup.com For more relevant conferences visit: http://www.conferenceseries.com/immunology-conferences.php Vaccines & VaccinationHyderabad November 02-04, 2015 8th Indo Global Summit and Expo on November 02, 2015 Opening ceremony Keynote Forum Group photo Speaker Forum Exhibitions B2B Meetings Young Research forum November 03, 2015 Speaker Forum Exhibitions B2B Meetings Young Research forum EB Meeting Poster session November 04, 2015 Speaker Forum Exhibitions B2B Meetings Young Research forum Best poster awards Young Researcher awards Closing ceremony Conference Agenda Supporting Partners Editorial Board Members Journal of Vaccines & Vaccination, Journal of Clinical & Cellular Immunology, Journal of Allergy & Therapy Michael G. Hanna Chairman Chief Executive Officer Vaccinogen Inc., USA Discoverer - Developer, OncoVAX® Director, Frederick Cancer Research Center (1975-1983) Shoenfeld Yehuda Head Zabludowicz Center for Autoimmune Diseases Tel-Aviv University, Israel Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases Editor, Israel Medical Association Journal (IMAJ). Editor-in-chief of Autoimmunity Reviews, Co-editor of the Journal of Autoimmunity Nikolai Petrovsky Director of Endocrinology Medicine Flinders University India Editor-in-Chief Journal of Vaccines & Vaccination Tel: +61 8 82044572
- 2. http://vaccines.indoglobalsummit.com/ Vaccines India-2015 Invitation OMICS Group welcomes you to attend the 8th Indo Global Summit and Expo on Vaccines & Vaccination during November 02-04, 2015 at Hyderabad. We cordially invite all the participants who are interested in sharing their knowledge and research in the arena of Vaccines. Vaccines India-2015 anticipates more than 500 participants around the globe with thought provoking Keynote lectures, Oral and Poster presentations. The attending delegates include Editorial Board Members of related OMICS Group Journals. This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists. The intending participants can confirm their participation by registering for the conference along with your colleagues. Avail the delegate early bird offer. The main theme of the conference is “Harnessing the current research in vaccines and vaccination for the better future”. Regards, Vaccines India-2015 Operating Committee Benefits of attending: 1. All Program entry 2. Conference souvenir 3. Abstract publication with DOI 4. Abstracts will be published in our refereed journal as a special issue 5. 50% Discount on the manuscript publication fee 6. Certification by the organizing committee 7. 5% discount on the OMICS Group membership 8. Global networking with the experts across the World 9. Presentations from Renowned speakers 10. B2B Meetings 11. Best poster presentations will be Awarded 12. Young Research Forum For more relevant conferences visit: http://www.conferenceseries.com/immunology-conferences.php
- 3. http://vaccines.indoglobalsummit.com/ Vaccines India-2015 Iampleasedtoannouncethe8th IndiaGlobalSummitand Expo on Vaccines & Vaccination (Vaccines India-2015) to be held in in Hyderabad, India from November 2-4, 2015 with the OMICS International as conference organiser. This follows the success of the Vaccines-2013 meeting in Las Vegas and the Vaccines-2014 meeting recently held in Valencia, Spain. The theme of Vaccines India-2015 will be “Harnessing the current research in vaccines and vaccination for the better future”. This annual vaccine summit, which for the first time is being held in India,willbringtogethervaccineresearchers,postdoctoralfellows,students,clinicians, epidemiologists, public health professionals and industry representatives from around the world, providing them with the opportunity to report and discuss important scientific challenges and achievements in the vaccine field. Most importantly it will provide great opportunities for creation of new collaborations and linkages between academics, clinicians and industry. Such partnerships will be critical to translation of recent laboratory breakthroughs into the vaccines of tomorrow. Examples of the diversetopicsthatwillbecoveredinthiscomprehensiveconferenceinclude;vaccine antigen discovery, design, manufacture and formulation, animal models, human clinical trials, correlates of vaccine protection, novel delivery technologies, vaccine adjuvants,mucosalimmunology,innateimmunepathways,T-andB-cellimmunology, veterinary vaccines, DNA and RNA vaccines, live vectors, vaccine side effects, epidemiology and immunotherapy, amongst many others. Vaccine areas to be covered will include infectious disease, cancer, autoimmunity, Alzheimer’s disease and allergy. The meeting will focus on both basic immune mechanism studies and clinical vaccine advances. Through attendance at Vaccines India-2015, you will be able to share your research results with your colleagues and have opportunities to establish new academic and industry collaborations.We will also provide those presenting at Vaccines-2015 the opportunity to publish a manuscript from their talk in the Journal of Vaccines and Vaccination. Please consider joining us in Brisbane for an exciting vaccine meeting. Do not hesitate to get in touch with me if you have any suggestions or questions regarding the organisation of this meeting. Professor Nikolai Petrovsky President Vaccines India-2015 Editor-in-Chief, Journal of Vaccines and Vaccination Research Director, Vaxine Pty Ltd Flinders Medical Centre/Flinders University, Adelaide PresidentMessage
- 4. http://vaccines.indoglobalsummit.com/ Vaccines India-2015 Why to attend??? • Vaccines India-2015 could be an event that brings along a novel and International mixture of giant and medium Vaccinology innovation and incipient trends in vaccines and vaccination, leading universities and vaccinology, vaccination research analysis establishments creating the conference an ideal platform to share expertise, foster collaborations across trade and world, and assess rising technologies across the world. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Vaccinology research are hallmarks of this conference. • The scientific sessions of Vaccines India-2015 will focus on the Discover and Exploit Emerging Trends in Vaccines and Vaccination. • This conference serves as an International forum to bring you closer to key professionals to support your mutual understanding of the field, accelerate your research in the field and to enable you to contribute to the ultimate care of people in this very important way. • All abstracts will be published with DOI • Certificate of participation Business??? • Best platform to develop new partnership & collaborations • Best location to speed up your route into every territory in the World • 89% our conference attendees are the Key contact in their labs purchasing decisions • Our exhibitor booths were visited 4-5 times by 80% of the attendees during the conference • Past exhibitor’s feedback reveals ample of enquiries perceived from the conference attendees • Network development with both Academia and Business Why to Exhibit??? • One exhibit booth • 1 page publication of the exhibitor profile in the souvenir • Promotion through the conference website • Promotional video on company products during the conference (Post session and Breaks) • One complimentary scientific program registration • Logo recognition in the Scientific program, Conference banner and flyer • One A4 flyer insert in the conference kit • An opportunity to sponsor 1 Poster Presentation Award • Post conference -submission of the mailing list and more... For more relevant conferences visit: http://www.conferenceseries.com/immunology-conferences.php
- 5. http://vaccines.indoglobalsummit.com/ Vaccines India-2015 OMICS Group Journals • 400 Open Access Journals • 21 Day rapid review process • 30000 Editorial team, 35000 Reviewers team • 3.5 Million readers and high visibility • More than 100000 • Publication immediately after acceptance • Quality and quick editorial, review processing Key features • User friendly/feasible website translation of your paper to 50 world’s leading languages • Enhanced feature: Audio version of published paper • Digital articles to share and explore • Sharing option: Social networking enabled • Authors, reviewers and editors are provided with scientific credits OMICS Group Conferences • 300 Conferences all over the World every year • Well organized scientific program • Renowned speakers and scientists across the globe • Poster presentations and world class exhibits • Panel discussions and interactive sessions • B2B meetings • Perfect platform for Global Networking Key features • Presentation by renowned speakers from all over the world • Poster presentations and world class exhibits • Interactive Sessions • Platform for global networking • Connecting scientific community About Us Special Issues All accepted abstracts will be published in respective OMICS Group Journals Each abstract will be provided with digital Object Identifier by Previous conference Best Poster Awardees Rong Xu, Cardiff University, UK Daisy Vanrompay, Ghent University, Belgium Silvia Vendetti, Istituto Superiore di Sanità, Italy For more relevant conferences visit: http://www.conferenceseries.com/immunology-conferences.php
- 6. http://vaccines.indoglobalsummit.com/ Vaccines India-2015 Abeer S. Yamany, Zagazig University, Egypt Ana M. Espino, University of Puerto Rico, USA ndre Frenzel, Technische Universität Braunschweig, Germany Antoine Danchin, Institut Pasteur, France Ara Hovanessian, Université Paris Descartes, France Arin Ghasparian, Virometix Ltd, Switzerland Arvind Chhabra, University of Connecticut Health Center, USA Ayman M. Noreddin, Hampton University, USA Barbara P. Yawn, Olmsted Medical Center, USA Beka Solomon, Tel Aviv University, Israel Bhawna Rathi, Amity University, India Bokyu Kang, Green Cross Veterinary Products Co., Ltd Brian J Czerniecki, University of Pennsylvania, USA Carole Lavigne, National Microbiology Laboratory, Canada Chad Rittle, Chatham University, USA Chinnaswamy Jagannath, University of Texas, USA Daesub Song, Korea Research Institute of Bioscience and Biotechnology, South Korea Daming Zhu, National Institutes of Health, USA David Baxter, University of Manchester, UK Denis Vorobiev, Mechnikov Research Institute for Vaccine and Sera, Russia Edda Sciutto, Universidad Nacional Autonoma de Mexico, Mexico Edmund J. Gosselin, Albany Medical College, USA Ennio De Gregorio, Novartis Vaccines and Diagnostics, Italy Fabio T. M. Costa, University of Campinas, Brazil Fang-Ping Huang, Imperial College London, UK Farah Khan, Jamia Hamdard University, India Flavio Guimaraes da Fonseca, Universidade Federal de Minas Gerais (UFMG), Brazil Ganesh Raj Pant, Rabies Vaccine Production Laboratory, Nepal Glaucia Paranhos-Baccala, Fondation Mérieux, France Guo Aizhen, Huazhong Agricultural University, China Haileleul Negussie, Addis Ababa University, Ethiopia Henok Tadesse Ayele, Dilla University, South Ethiopia. Hiroshi Kido, Tokushima University, Japan Huijun Lu, Institute of Military Veterinary, P.R. China Jignasa K. Savjani, Nirma University, India Jimmy Kwang, National University of Singapore, Singapore K. Zaman, International Centre for Diarrhoeal Disease Research, Bangladesh Kari Auranen, National Institute for Health and Welfare, Finland Kei Amemiya, US Army Medical Research Institute, USA Lakshmi Krishnan, National Research Council-Institute, Canada Laura Manna, Naples University School of Veterinary Medicine, Italy Luciano Polonelli, University of Parma, Italy Lul Raka, University of Prishtina, Kosovo Mansour Mohamadzadeh, University of Florida, USA Marc H.V. Van Regenmortel, University of Strasbourg, France Maria Eugenia Rodriguez, La Plata University School of Sciences, Argentina Mark Estes, University of Georgia College of Veterinary Medicine, USA Mark Malek, UCLA School of Public Health, USA Mark S. Kindy, Medical University of South Carolina, USA Masoud H Manjili, Virginia Commonwealth University, USA Mei X. Wu, Harvard Medical School, USA Michael G. Agadjanyan, Institute for Molecular Medicine( IMM), USA Michael Greger, Humane Society International, USA Mohamed L. Salem, Tanta University, Egypt Nina G. Gloriani, University of Philippine, Philippines Nisha Jain Garg, University of Texas Medical Branch, USA Obaidul Malek, Ryerson University, Cana Olga Borges, University of Coimbra, Portugal Olga Perovic, University of Witwatersrand, South Africa Pallavi Somvanshi, Gautam Buddha Technical University, India Periasamy Selvaraj, Emory University, USA Philip O Livingston, MabVax Therapeutics Inc., USA Pranita Roy, Amity University, India Praveen Guturu, University of Texas Medical Branch, USA Ran Zichel, The Israel Institute for Biological Research, Israel S. Fernando Ausar, Sano, Saber Gholizadeh, Urmia University of Medical Sciences, Iran Sattva S.Neelapu, The University of Texas M.D. Anderson Cancer Center, USA Sharad Mangal, Shantha Biotechnics Ltd, India Silvia Vendetti, Istituto Superiore di Sanità, Italy Sontakke U.B, National Dairy Research Institute, India Sudipta Bhowmick, University of Calcutta, India Tarek M. Fahmy, Yale University, USA Toshihiro Horii, Osaka University, Japan Vipin Kumar Deo, Shizuoka University, Japan Xiaohua Qian, The Center for Disease Control and Prevention, China Y. D. Sharma, All India Institute of Medical Sciences, India Yanwei Zhong, Beijing 302 Hospital, China Yasuyuki Ishi, Riken, Japan Yuri Garcia Cortez, Ricardo Palma University, Peru Yutaka Kishida, Osaka Kaisei Hospital, Japan A. Bennett Jenson, University of Louisville, USA Abdur Razzaque Sarker, International Centre for Diarrhoeal Disease Research, Bangladesh Ahtisham Ul Haq, Service Institue of Medical Sciences, Pakistan Aideen Kennedy, Animal & Grassland Research and Innovation Centre, Ireland Alan R Shaw, Vedantra Pharmaceuticals, USA Ali Azizi, Sanofi Pasteur, Canada Alwyn Rapose, Reliant Medical Group, USA Amira SOUII, Université de Tunis El Manar, Tunisia Anastasia Latanova, Karolinska Institutet, Sweden Andreas Meinke, Valneva Austria GmbH, Austria Andy (Qigui) Yu, Indiana University School of Medicine, USA Ara Hovanessian, CNRS - Université Paris Descartes, France Arfa Moshiri, Shahid Beheshti University of Medical Sciences, Iran AS Mustafa, Kuwait University, Kuwait Athina KILPELAINEN, Karolinska Institutet, Sweden Atsuko Hata, The Tazuke Kofukai Medical Research Institute, Japan Banri Tsuda, Tokai University School of Medicine, Japan Barbara Kalenik, Institute of Biochemistry and Biophysics Polish Academy of Sciences, Poland Beatriz Basso, National University of Cordoba, Argentina Benjamin Petsch, CureVac GmbH, Germany Bernadette Ferraro, University of Pennsylvania, USA Bhawna Rathi, Amity University, India Bingdong Zhu, Lanzhou University, China Birgitta Henriques-Normark, Karolinska Institute, Sweden Brenda S. Atchison, The Alliance for Multispecialty Research, LLC Brian Abel, Singapore Immunology Network, Singapore Our Previous Vaccines Conferences Attendees For more relevant conferences visit: http://www.conferenceseries.com/immunology-conferences.php
- 7. http://vaccines.indoglobalsummit.com/ Vaccines India-2015 Brian K. Meyer, Merck & Co, USA Campbell Bunce, Immune Targeting Systems Ltd, UK Carmen Alvarez-Dominguez, Instituto de Formacion e Investigacion Marques de Valdecilla, Spain Chetan V. Jawale, Chonbuk National University, Korea Chih-Hsiang Leng, National Health Research Institutes, Taiwan Chil-Yong Kang, The University of Western Ontario, Canadav Christiane Juhls, MOLOGEN AG, Germany Christina Rueckert, Helmholtz Center for Infection Research, Germany Claudia Facciotti, Novartis, Italy Claudia Palena, National Institutes of Health, USA Cody Towler, Clinical Research Consortium, USA Connie S Schmaljohn, United States Army Medical Research Institute of Infectious Diseases, USA Coreen M. Beaumier, Sabin Vaccine Institute, USA Cory Robinson, The University of South Carolina School of Medicine, USA Cynthia Dukes, ICON Clinical Research, USA D.N. Rao, All India Institute of Medical Sciences, India Daming Zhu, National Institutes of Health, USA Daniel H Zimmerman, CEL-SCI Corporation, USA Daniela Pencheva, Bul Bio - NCIPD Ltd, Bulgaria David E Anderson, VBI Vaccines, USA Deborah H. Schmiel, Walter Reed Army Institue of Research, USA De-chu C. Tang, International Vaccine Institute, Korea De-Chu Christopher Tang, Vaxin Inc., USA Diane Longo, Nodality, USA Didier Betbeder, University of Luille2, France Donald E. Greydanus, Western Michigan University School of Medicine, USA Dongbo Jiang, The Fourth Military Medical University, P.R.China Elena Curti, Baylor College of Medicine, USA Eli Young, OpSaniTx, USA Elizaveta Starodubova, Karolinska Institutet, Sweden Engy M. El-Ghitany, Alexandria University, Egypt Eric Cox, Ghent University, Belgium Eric James Gowans, The University of Adelaide, South India Ernesto Mejias Perez, Centro Nacional de Biotecnología, Spain Esma S. Yolcu, University of Louisville, USA Evette Riegel, Beardsworth Consulting Group, USA Fermin J. Gonzalez-Melado, Pontifical Institute “John Paul II” for Studies on Marriage and Family, Spain Filipe Colaco Mariz, Federal University of Pernambuco, Brazil Filippo de Nicolellis, Primary Health Care, Italy Francesco Berti, Novartis Vaccines, Italy Frank J. Malinoski, Liquidia Technologies Inc., USA Frederic DESCHAMPS, University Hospital of Reims, France Gary Kobinger, Public Health Agency of Canada, Canada Gavin Zealey, Sanofi Pasteur, Canada Geert Vanden Bossche, UNIVAC LLC, Belgium Gene Garrard Olinger, United States Army Medical Research Institute of Infectious Diseases, USA Gerald R. Kovacs, U.S. Department of Health and Human Services, USA Gerardo Kaplan, Food and Drug Administration, USA Gisela Gonzalez, Center of Molecular Immunology, Cuba Gisela Gonzalez Marinello, Center of Molecular Immunology, Cuba Giulio Tarro, Temple University Center for Biotechnology, USA Graham Clarke, ImmunoBiology Ltd, UK Guoquan Zhang, University of Missouri-Columbia, USA Gwo-Yu Chuang, National Institutes of Health, USA Harry Kleanthous, Sanofi-Pasteur, Inc. Haval Shirwan, University of Louisville, USA Heather L Wilson, University of Saskatchewan, Canada Hemanta Koley, National Institute of Cholera and Enteric Diseases, India Hong Sun, Sanofi Pasteur, Canada Hong Xin, LSUHSC & Children’s Hospital Research Institute, USA Humberto Hernandez, University of Texas Medical Branch, USA Hyo-Ihl Chang, Korea University, Korea Hyunah Lee, Samsung Medical Center, Sungkyunkwan University School of Medicine Igor S. Lukashevich, University of Louisville, USA Inkar Castellanos, Viren SA de CV, Mexico Isiaka Alade Owolabi, Tshwane University of Technology, South Africa Jake Darpine B. Banggay, University of Southern Mindanao, Korea Javed N Agrewala, CSIR - Institute of Microbial Technology, India Jay Bream, Johns Hopkins Bloomberg School of Public Health, USA Jean L Patterson, Texas Biomedical Research Institute, USA Jean-Pierre Y. Scheerlinck, The University of Melbourne, India Jeffrey Ulmer, Novartis Vaccines & Diagnostics, USA Jerome Jacques, Food and Drug Administration, USA Jimmy Kwang, National University of Singapore, Singapore Jin Wang, Baylor College of Medicine, USA John Dong, GenPhar Inc., USA John Eldridge, Profectus BioSciences, USA Joongho Joh, University of Louisville, USA Jorge G. Gomez-Gutierrez, University of Louisville, USA Jose Ronnie Vasconcelos, Federal University of Sao Paulo, Brazil Joseph Horzempa, West Liberty University, USA Joseph Larkin, University of Florida, USA Joseph Onakewhor, University of Benin Teaching Hospital, Nigeria Julia A. Walsh, University of California Berkeley, USA Julitasari Sundoro, Indonesian Technical Advisory Group on Immunization, Indonesia Junichiro Mizuguchi, Tokyo Medical University, Japan Kaissar Tabynov, Research Institute for Biological Safety Problems, Kazakhstan Kate E. Broderick, Inovio Pharmaceuticals, USA Katie Ewer, University of Oxford, UK Kei Amemiya, U.S. Army Medical Research Institute of Infectious Diseases, USA Krishnamurthy Konduru, Food and Drug Administration, USA Kristy M. Ainslie, The Ohio State University, USA Kuo-I Lin, Genomics Research Center, Taiwan Kwang Poo Chang, Chicago Medical School/RFUMS, USA KyungDong Bae, Crucell Korea, Korea Lakshmi Krishnan, National Research Council-Human Health Therapeutics, Canada Langzhou Song, VaxInnate Corporation, USA Latifynia Afshineh, Tehran University of Medical Sciences, Iran Laura Manna, Naples University School of Veterinary Medicine, Italy Leonard A Smith, United States Army Medical Research Institute of Infectious Diseases, USA Leow Yee, Queensland Institute of Medical Research, India Lijuan Yuan, Virginia Polytechnic Institute and State University, USA Ljiljana Majnaric Trtrica, JJ Strossmayer University, Croatia Lucyna Cova, INSERM, France M E Hoque, University of KwaZulu-Natal, South Africa For more relevant conferences visit: http://www.conferenceseries.com/immunology-conferences.php Our Previous Vaccines Conferences Attendees
- 8. http://vaccines.indoglobalsummit.com/ Vaccines India-2015 Maarten J Postma, University of Groningen, The Netherlands Magdalena Tary-Lehmann, Cellular Technology Limited, USA Maher Gandhi, Queensland Institute of Medical Research, India Malcolm E Thomas, Arbovax., Inc Malcolm Thomas, Arbovax Inc, USA Manmohan Singh, Novartis Vaccines, USA Marc Bonneville, Inserm-Nantes University, France Marc GREGOIRE, Institut de Recherche en Santé Université de Nantes, INSERM Marcel Thalen, Iliad Biotechnologies, Scotland Maria Foti, University of Milano-Bicocca, Italy Maria Gomes-Solecki, University of Tennessee Health Science Center, USA Maria Helena Bueno da Costa, Scientific Consultant, France Maria ISAGULIANTS, Karolinska Institutet, Sweden; Riga Stradins Univeristy Mark Schwartz, Galena Biopharma Inc, USA Martin J. D’Souza, Mercer University, USA Mauro Di Pilato, Centro Nacional de Biotecnología, Spain Maya Salnikova, Merck & Co. Inc., USA Megha Kadam Bedekar, Central Institute of Fisheries Education, India Melha Mellata, Arizona State University, USA Michael G. Hanna, Vaccinogen, Inc. Michael Hust, Technische Universität Braunschweig, Germany Michael S. Taitel, Walgreen Co., USA Michael Vajdy, EpitoGenesis Inc., USA Michele Gerber, Astellas Pharma Global Development Inc., USA Milan Raska, Palacky University, Czech Republic Min Shi Lee, National Health Research Institutes, Taiwan Mineo Matsumoto, Pharmaceutical and Medical Devices Agency, Japan Miroslav Toman, Veterinary Research Institute, Czech Republic Molalegne Bitew, Jimma University, Ethiopia Muhammad Ali A Shah, Southeast University, China Nathaly Arndtz-Wiedemann, Bavarian Nordic GmbH, Germany Nikolai Petrovsky, Flinders Medical Centre Research, India Nisha Nair, Amrita Centre for Nanosciences and Molecular Medicine, India Obradovic Zarema, University of Sarajevo, Bosnia and Herzegovina Omer Qutaiba B. Al-lela, International Islamic University Malaysia, Malaysia Pamuk Bilsel, Flugen Inc., USA Patrice DEBRE, INSERM, France Pedro Reis, AC Immune, Switzerland Pele Choi-Sing Chong, National Health Research Institutes, Taiwan Periasamy Selvaraj, Emory University, USA Peter L Nara, Biological Mimetics Inc., USA Peter L. Nara, Biological Mimetics, Inc. Phil Sutton, Murdoch Childrens Research Institute, India Pirouz Daftarian, University of Miami, USA Ponomaryova Tatyana, Kazakh Scientific Center of Quarantine and Zoonotic Diseases, Kazakhstan Pranav Gupta, Morehouse School of Medicine, USA Rainer Fischer, Fraunhofer IME, Germany Rajesh Kumar Sharma, University of Louisville, USA Rakesh Kumar, Serum Institute of India Limited, India Ramaswamy Kalyanasundaram, University of Illinois, USA Ranadhir Dey, Food and Drug Administration, USA Randa Hamadeh, Ministry of Public Health, Lebanon Raphael Ho Tsong Fang, InnaVirVax, France Rashika El Ridi, Cairo University, Egypt Ray Spier, University of Surrey, UK Regis Sodoyer, Sanofi Pasteur, France Rene Rachou Research Center, Brazil, Richard T Wyatt, The Scripps Research Institute La Jolla, USA Ríona Sayers, Animal & Grassland Research and Innovation Center, Ireland Robert E. Sievers, University of Colorado, USA Robin Levis, Food and Drug Administration, USA Rocky M. Cranenburgh, Prokarium Ltd, UK Rong Xu, Cardiff University, UK Rongtuan Lin, McGill University, Canada Rudolf Toman, Slovak Academy of Sciences, Slovak Republic Sana Shahram, University of British Columbia, Canada Sandybayev Nurlan, Research Institute for Biological Safety Problems, Republic of Kazakhstan Saroj Basak, University of California Los Angeles, USA Scott I. Abrams, RoswellPark Cancer Institute, USA Sean Tucker, Vaxart, Inc. Serge Ohreser, Merck Millipore, France Seyed Davar Siadat, Pasteur Institute of Iran, Iran Silvia Pellicer, World Pathol, Spain Silvia Vendetti, Istituto Superiore di Sanità, Italy Srinivas Reddy, Serum Institute of India Ltd, India Stefan Petkov, Karolinska Institutet, Sweden Sunil K Arora, PGIMER, India Sunil Palchaudhuri, WSU School of Medicine, USA Sylvain Haba, Centre Des Soins Medico-Tradi-Spirituels Talithakoumi, Guinea Conakry Takashi Kei Kishimoto, Selecta Biociences, USA Takehiko Okamura, J.A.Aichi Anjo Kosei Hospital, Japan Tatjana Pljesa, Institute of Virology, Vaccines and Sera Torlak Teena Mohan, All India Institute of Medical Sciences, India Thomas M. Yankee, University of Kansas Medical Center, USA Tian Wang, The University of Texas Medical Branch, USA Timothy Fouts, Profectus BioSciences, Inc. Timothy Lee, Latham Biopharm Group, USA Tjip van der Werf, University of Groningen, The Netherlands Trilochan Mukkur, Curtin University of Technology, Western India Ursula Wiedermann, Medical University of Vienna, Austria Venky Ramakrishna, Celldex Therapeutics, USA Vikrant Sudan, College of Veterinary Sciences and Animal Husbandry, DUVASU Vinod Mrithinjayam, Accenture Management Consulting, India Wei Kong, Arizona State University, USA Wei-Mei Ching, Naval Medical Research Center, USA William Hildebrand, The University of Oklahoma Health Sciences Center School of Medicine, USA William J. Murphy, UC Davis School of Medicine, USA Xiaoqing Wei, Cardiff University, UK Xueqiong Wu, Institute for Tuberculosis Research, China Y.D. Sharma, All India Institute of Medical Sciences, India Yahia Chebloune, CNRS-Universite Joseph Fourier, France Yared Hailemichael, The UT MD Anderson Cancer Center, USA Yongqun “Oliver” He, University of Michigan Medical School, USA Yutaka Tagaya, University of Maryland School of Medicine, USA Yuzhang Wu, Third Military Medical University, China Zakaria Hmama, University of British Columbia, Canada Zarema Obradovic, University of Sarajevo, Bosnia and Herzegovina Zelig Eshhar, The Weizmann Institute of Science, Israel For more relevant conferences visit: http://www.conferenceseries.com/immunology-conferences.php Our Previous Vaccines Conferences Attendees
- 9. http://vaccines.indoglobalsummit.com/ Vaccines India-2015 AboutHyderabad India was one among leaders when vaccine research began to gain importance in the rest of the World and continues to do so even today despite some lag period during I& II World war and the following period till 1970s. Several dedicated vaccine R&D institutions were set up between the 1950s-1980s with the help of Rockefeller foundation, UNICEF etc., and the real emphasis on vaccine research was initiated and promoted by the Department of Biotechnology (DBT) that was set up in 1986. In fact, DBT’s initiative gave tremendous boost to vaccine research and development (R&D) in this country and the following description and the table presents the evidence. However, these indigenous efforts have not yet been translated into appropriate use for Indian masses. Vaccine R&D Institutions in India There are around 26 vaccine R&D institutions in India that are actively engaged in research and development of vaccines, as of today. There are 2 institutes under DBT (came up in late 1980s), 11 under ICMR (came up between 1950s - 1990s), 6 under CSIR, and others include university departments and other autonomous institutions like AIIMS Hyderabad, IISC Bangalore etc. Out of these Central Research Institute, Kasauli; Haffkine Institute (HI), Mumbai; King Institute of Preventive Medicine, Chennai; and Pasteur Institute of India(PII), Coonoor are century old institutes that came up during British India. Their institutional structures are based on the innovation model where R&D and Production co-exist under the same roof. This was basically to facilitate research that would lead to vaccine development against a particular disease and transfer of technology to the production division. This model facilitated better and faster coordination between R&D and production divisions, for scaling up technology and other improvements and technological up-gradation. Rest of the research institutions that were set up after independence are dedicated to research and development of vaccines. For more relevant conferences visit: http://www.conferenceseries.com/immunology-conferences.php
- 10. http://vaccines.indoglobalsummit.com/ Vaccines India-2015 Venue Conference Dates:October 26-28, 2015 Hyderabad International Convention Centre Novotel & HICC Complex (Near Hitec City) P.O Bag 1101 Cyberabad Post Office Hyderabad - 500 081 India Important Dates Abstract submission opens: March 15, 2015 Registration opens: April, 2015 Early bird registration: April 28th, 2015 On spot registration: November 02, 2015 About Us Who can attend ? • Vaccine professionals • Doctors • President related to Vaccine department • Vice President • Fellowship Directors • Professors • Associate Professors • Assistant Professors • Researchers • Ph.D students • Lecturer • Research Fellows • Head of Department • Pharmaceutical vaccine manufacturers • Large / mid cap biotech • SME biotech • Academia / research institutes • Governmental / public health / payers • Investors • Consultants • Selected contract service providers • Graduate Students • Specialists For more relevant conferences visit: http://www.conferenceseries.com/immunology-conferences.php
- 11. http://vaccines.indoglobalsummit.com/ Vaccines India-2015 Previous Highlights International Conference and Exhibition on Vaccines & Vaccination October 19-21, 2015 San Francisco, USA 2nd International Conference on Vaccines & Vaccination August 20-22, 2012 Hilton Chicago/Northbook, USA 3rd International Conference on Vaccines & Vaccination July 29-31, 2013 Embassy Suites Las Vegas, USA 4th International Conference on Vaccines & Vaccination September 24-26, 2014 Valencia, Spain Previous sponsors: Upcomming Vaccines Conferences 6th Euro Global summit and Expo on Vaccines & Vaccination Aug 17-19, 2015 Birmingham, UK URL: http://vaccines.global-summit.com/europe/index.php 7th Dubai Global summit and expo on Vaccines & Vaccination Sep 28-30, 2015 Dubai, UAE URL: http://vaccines.global-summit.com/middleeast/index.php 8th American Global summit and Expo on Vaccines & Vaccination Oct 05-07, 2015 San Francisco, USA URL: http://vaccines.global-summit.com/america/inex.php India Global Summit and Expo on Vaccines & Vaccination July 27-29, 2015 Brisbane, India URL: http://vaccines.global -summit.com/asia-pacific For more relevant conferences visit: http://www.conferenceseries.com/immunology-conferences.php